About StemOnc
StemOnc is a company based in Chennai (India). It operates as a Biopharma Outsourcing. StemOnc offers products and services including StemOnc Platform.
- Headquarter Chennai, India
- SectorsHealthcare
- Website stemonc.com
- Legal Name Stemonc R&D Private Limited
- Date of Incorporation 07 Jun, 2019
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹23,080
FY 2024 · -97% YoY
- Net Loss-₹1.5 Lakh
FY 2024 · -671% margin
- EBITDA-₹1.5 Lakh
FY 2024 · -659% margin
Associated legal entities of StemOnc
StemOnc operates through Stemonc R&D Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stemonc R&D Private Limited CIN U73100TN2019PTC129769 | Active | 07 Jun 2019 | Chennai, Tamil Nadu | ₹0.0 Cr | – | 2 | View details |
Products & Services of StemOnc
StemOnc offers a comprehensive portfolio of products and services, including StemOnc Platform.
Provider of drug discovery on molecular biology services
Board of directors of Stemonc R&D Private Limited (StemOnc)
Stemonc R&D Private Limited is the primary company behind StemOnc. The board of Stemonc R&D Private Limited currently have 2 directors; the longest-serving is Thirumurthy Madhavan, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Thirumurthy Madhavan DIN 08474546 | Director | 07 Jun 2019 | 7 yrs 4 mo | Stemonc R&D Private Limited |
| Satish Ramalingam DIN 08474547 | Director | 07 Jun 2019 | 7 yrs 4 mo | Stemonc R&D Private Limited |
Financials of StemOnc
Figures of Stemonc R&D Private Limited, the primary company behind StemOnc, for FY 2024. Revenue was ₹23,080 (-97% year on year). Net loss was -₹1.5 Lakh (-671% margin). EBITDA was -₹1.5 Lakh (-659% margin). Revenue has grown at a compounded annual rate of +185% over three years.
- ₹23,080Revenue · FY 2024 · -97% YoY
- -₹1.5 LakhNet loss · -671% margin
- -₹1.5 LakhEBITDA · -659% margin
- ₹1 LakhPaid-up capital
- +185%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Stemonc R&D Private Limited are on its company page.
Detailed financial statements for StemOnc
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to StemOnc
10 companies that operate in the same segment as StemOnc (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about StemOnc
StemOnc is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
The primary company behind StemOnc, Stemonc R&D Private Limited, reported revenue of ₹23,080 for FY 2024, down 97% year on year.
StemOnc, based in Chennai, focuses on drug discovery, companies, biopharma outsourcing, and companies offering comprehensive services for drug discovery. Provider of drug discovery on molecular biology services. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
StemOnc offers StemOnc Platform.
StemOnc operates through Stemonc R&D Private Limited.
The legal entities of StemOnc currently have 2 directors, including Thirumurthy Madhavan, Satish Ramalingam.